In one paragraphReview in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Tonathiu RodríguezLaboratorio de Inmunidad Innata, Unidad de Investigación en Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala (FES-I), Universidad Nacional Autónoma de México (UNAM), Av. de los Barrios 1, Los Reyes Iztacala, Tlalnepantla 54090, Estado de México, Mexico.ORCID 0000-0002-5895-1648 Víctor H Salazar-CastañónLaboratorio de Inmunología Molecular, Unidad de Investigación Química Computacional, Síntesis y Farmacología en Moléculas de Interés Biológico, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México (UNAM), Batalla 5 de Mayo esquina Fuerte de Loreto, Iztapalapa 09230, Ciudad de México, Mexico.ORCID 0000-0003-3620-7858 Luis I TerrazasLaboratorio de Inmunoparasitología, Unidad de Investigación en Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala (FES-I), Universidad Nacional Autónoma de México (UNAM), Av. de los Barrios 1, Los Reyes Iztacala, Tlalnepantla 54090, Estado de México, Mexico.ORCID 0000-0003-4649-4117 Imelda Juárez-AvelarLaboratorio de Inmunidad Innata, Unidad de Investigación en Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala (FES-I), Universidad Nacional Autónoma de México (UNAM), Av. de los Barrios 1, Los Reyes Iztacala, Tlalnepantla 54090, Estado de México, Mexico.
Miriam Rodríguez-SosaLaboratorio de Inmunidad Innata, Unidad de Investigación en Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala (FES-I), Universidad Nacional Autónoma de México (UNAM), Av. de los Barrios 1, Los Reyes Iztacala, Tlalnepantla 54090, Estado de México, Mexico.ORCID 0000-0003-2911-9390 Funding
Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (DGAPA), Universidad Nacional Autónoma de México (UNAM) IN208126Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (DGAPA), Universidad Nacional Autónoma de México (UNAM) IV200425
6 · The paper itselfAbstract
Some parasitic infections promote or inhibit vascular growth in their hosts to increase parasite survival through immune evasion and tissue dissemination. This review focuses on how the most prevalent protozoan and helminth parasites in humans, such as
Indexed as
AngiogenesisHost-Parasite InteractionsNeovascularization, PathologicParasitesParasitic DiseasesAnimalsHumansamebiasisangiogenesishelminthsHIF-1αhypoxiaimmune modulationleishmaniasismalariamatrix metalloproteinasesneurocysticercosisparasitic infectionprotozoaschistosomiasistoxoplasmosistrypanosomiasisvascular remodelingVEGF
Identifiers
PMID42075674
PMCPMC13119193
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390